𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Detecting treatment-by-centre interaction in multi-centre clinical trials

✍ Scribed by Richard F. Potthoff; Bercedis L. Peterson; Stephen L. George


Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
144 KB
Volume
20
Category
Article
ISSN
0277-6715

No coin nor oath required. For personal study only.

✦ Synopsis


This paper considers several permutation tests for treatment-by-centre interaction in multi-centre clinical trials in which the endpoint is survival time subject to censoring. Some of the tests are based on existing tests and some are new. To evaluate and compare the tests with respect to power under different conditions, we generated survival times and censoring times through simulation. We used special methodology to handle the unusual problems that arise in power simulations when the tests under study are permutation tests. Different conditions yielded different interaction tests as the best performers. Although one test gave comparatively good power under almost all conditions, some of the other tests also appear to be useful. For the sample sizes and configurations in the simulations, power is generally low; thus it may not be possible to detect interaction reliably when it exists, a finding in agreement with the known low power for interaction tests in general.


πŸ“œ SIMILAR VOLUMES


Investigating centre effects in a multi-
✍ Takuhiro Yamaguchi; Yasuo Ohashi πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 112 KB πŸ‘ 2 views

This paper examines the amount of variation among centres and estimates the overall e!ect of therapy in a multi-centre cancer clinical trial with censored failure time data. To investigate the centre e!ects, the variation in the treatment e!ect must be taken into consideration in addition to the var

A comparison of various estimators of a
✍ B. Jones; D. Teather; J. Wang; J. A. Lewis πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 96 KB πŸ‘ 2 views

When a clinical trial is conducted at more than one centre it is likely that the true treatment effect will not be identical at each centre. In other words there will be some degree of treatment-by-centre interaction. A number of alternative approaches for dealing with this have been suggested in th

A Bayesian hierarchical survival model f
✍ Yutaka Matsuyama; Junichi Sakamoto; Yasuo Ohashi πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 159 KB πŸ‘ 2 views

In randomized clinical trials comparing treatment effects on diseases such as cancer, a multi-centre trial is usually conducted to accrue the required number of patients in a reasonable period of time. While we interpret the average treatment effect, it is necessary to examine the homogeneity of the

AN INDEX FOR ASSESSING BLINDNESS IN A MU
✍ KENNETH E. JAMES; DANIEL A. BLOCH; KELVIN K. LEE; HELENA C. KRAEMER; RICHARD K. πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 819 KB

This paper considers an index to assess the success of blinding with application to a clinical trial of disulfiram. The index increases as the success of blinding increases, accounts for uncertain responses, and is scaled to an interval of 0 0 to 1.40-0 being complete lack of blinding and 1.0 being

A prospective trial of the tnm classific
✍ E. N. Mackay; A. H. Sellers πŸ“‚ Article πŸ“… 1970 πŸ› John Wiley and Sons 🌐 French βš– 598 KB

## Abstract As its contribution to the 1960–64 clinical trial of the TNM Classification of breast cancer, The Ontario Cancer Treatment and Research Foundation reviewed in detail the distribution and 5‐year survival of 1,846 female patients classified according to TNM criteria. While further conside